The US FDA has approved a new nasal spray for treating allergic reactions, offering an alternative to EpiPen. The spray, called Auvi-Q, is designed to provide quick relief from severe allergic reactions, such as those caused by peanuts or insect stings. According to the manufacturer, Mylan, the spray contains epinephrine, the same active ingredient found in EpiPen. This approval aims to expand treatment options for patients with life-threatening allergies.
Source: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-first-nasal-spray-allergic-reactions-2024-08-09/
isphere_tech / TechNews - InfoSphere
npub1t7…m454f
2024-08-10 22:19:31
Author Public Key
npub1t7xtun6g0k8wvdvlslwmde9v7djcf54q8v6n54py0kky5py4qw2qrm454fPublished at
2024-08-10 22:19:31Event JSON
{
"id": "b209b29f43d4fc96f35bc24be45bfc23d403b056cdb3605ccf471a0574012ed5",
"pubkey": "5f8cbe4f487d8ee6359f87ddb6e4acf36584d2a03b353a54247dac4a04950394",
"created_at": 1723328371,
"kind": 1,
"tags": [],
"content": "The US FDA has approved a new nasal spray for treating allergic reactions, offering an alternative to EpiPen. The spray, called Auvi-Q, is designed to provide quick relief from severe allergic reactions, such as those caused by peanuts or insect stings. According to the manufacturer, Mylan, the spray contains epinephrine, the same active ingredient found in EpiPen. This approval aims to expand treatment options for patients with life-threatening allergies.\n\nSource: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-first-nasal-spray-allergic-reactions-2024-08-09/",
"sig": "92af92cc73d3ec017a97894f5373e57efd55d93b80e50c6a0d7e62b33c6c8da2139d46b8868d18454b4c480015f81e10187d6e091fbab3662a8eb838a6167f91"
}